ZeroTo510
Overview
ZeroTo510 is a Memphis-based medical technology accelerator program that supports early-stage founders with an intensive, cohort-based program focused on commercialization and navigating the regulatory landscape.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Future Cardia | Jun 2019 | Pre Seed | Lead |
| Hera Health Solutions | Aug 2018 | Seed | Co-investor |
| PATH EX, Inc. | - | Accelerator | Co-investor |
| Corami Biotech Inc. | Sep 2024 | Accelerator | Co-investor |
| SOMAVAC Medical Solutions, Inc. | Nov 2016 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is ZeroTo510 based?
ZeroTo510 is headquartered in Memphis, Tennessee, United States.
When was ZeroTo510 founded?
ZeroTo510 was founded in 2012.
How many portfolio companies does ZeroTo510 have?
ZeroTo510 has 7 portfolio companies in Caplight's dataset.
What are some companies in ZeroTo510's portfolio?
Portfolio companies visible on Caplight include Future Cardia, Hera Health Solutions, PATH EX, Inc., Corami Biotech Inc., SOMAVAC Medical Solutions, Inc..
What was ZeroTo510's most recent investment shown here?
ZeroTo510's most recent investment in this portfolio sample was in Corami Biotech Inc. in 2024.
What sectors does ZeroTo510 focus on?
ZeroTo510 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does ZeroTo510 focus on?
ZeroTo510 typically invests at the Early stage.